PET imaging for lymph node dissection in prostate cancer.

about

Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.

P2860

Q47097602-564BA03B-BC63-4C8C-8665-57452CD9FAC2

P2860

PET imaging for lymph node dissection in prostate cancer.

Item

http://www.wikidata.org/entity/Q38983526

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

PET imaging for lymph node dissection in prostate cancer.

@en

type

Item

label

PET imaging for lymph node dissection in prostate cancer.

@en

prefLabel

PET imaging for lymph node dissection in prostate cancer.

@en

P1476

PET imaging for lymph node dissection in prostate cancer

@en

P2093

Luigi Gianolli

http://www.w3.org/2001/XMLSchema#string

P2860

New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.

[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005

Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

Pelvic lymph node dissection in prostate cancer.

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.

18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

P2888

s00345-016-1954-8

P304

507-515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00345-016-1954-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paola Mapelli

Maria Picchio

Elena Incerti

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024779875

http://www.w3.org/2001/XMLSchema#string

P698

27752756

http://www.w3.org/2001/XMLSchema#string

PET imaging for lymph node dissection in prostate cancer.

about

P2860

P2860

PET imaging for lymph node dissection in prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698